Natural Alternatives International trades as part of the consumer defensive sector and is part of the consumer packaged goods industry. The company CEO is Mark A. LeDoux. Natural Alternatives International provides contract manufacturing services to companies that market and distribute vitamins, minerals, herbs and other nutritional supplements, as well as other health care products to customers within and outside the U.S.
Previous Intraday Performance:
The NAII shares had a previous change of 2.68% which opened at 12.81 and closed at 13.04. It moved to an intraday high of 13.04 and a low of 12.70.
Over the last five trading days, NAII shares returned -4.61% and in the past 30 trading days it returned 5.08%. Over three months, it changed 23.84%. In one year it has changed 23.60% and within that year its 52-week high was 14.25 and its 52-week low was 8.73. NAII stock is 49.31% above its 52 Week Low.
Our calculations result in a 200 day moving average of 10.66 and a 50 day moving average of 12.31. Right now, NAII stock is trading 22.38% above its 200 day moving average.
The company has a market cap of $94.7m with 7.3m shares outstanding and a float of 5.7m shares. Trading volume was 2,637 shares and has experienced an average volume of 11,265 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.
The last annual reported EPS for Natural Alternatives International was 0.72 which ended on 30th of June 2018, which according to the previous close, that is a PE of 18.11.
The next earnings report will be: 06-04-2019
The growth of the EPS is critical in understanding the current valuation of Natural Alternatives International; it is typically displayed as a percentage and called the EPS growth rate, which at this time is hard to estimate, but revenue growth has been 12.10% over the last twelve months.
Indicators Also to Watch:
Based on the latest filings, there is 46.20% of institutional ownership.
I calculated the beta to be 0.16
Based on last reported financials, the company’s return on equity is 14.33%, return on assets is 10.76%, profit margin is 6.39%, price-to-sales is 0.63 and price-to-book is 1.20.
Company Score Card:
Results are out of six:
3 : Growth Expectations Result
6 : Financial Safety Result
3 : Past Performance Result
3 : Valuation Result
0 : Dividend Safety Result
3 : Overall Result